TD139: Phase Ib data

Data from 36 healthy male volunteers in the Phase Ib portion of a double-blind, placebo-controlled, U.K. Phase Ib/IIa trial showed that single ascending doses of 0.15-50 mg inhaled TD139 were safe and...